clinical trial allopurinol Zyloric myocardial protection study myocardial protective effects allopurinol various doses Ninety patients undergoing coronary artery bypass repair replacement cardiac valves groups patients accordance amount allopurinol patients group Patients group allopurinol group II low-dose allopurinol total dose mg group III high-dose allopurinol total dose mg Aspartate aminotransferase cardiac isoenzyme creatine kinase lactic dehydrogenase levels days operation Concentrations allopurinol oxypurinol initiation cardiopulmonary bypass start end aortic crossclamping Postoperative aspartate aminotransferase creatine kinase lactate dehydrogenase lactate dehydrogenase levels group III groups II Aspartate aminotransferase creatine kinase lactate dehydrogenase lactate dehydrogenase levels group II group significant differences Plasma oxypurinol concentrations group III group II allopurinol resultant high myocardial protective effects dose-related fashion effect levels degradation 